Androgen agents in combination with gestagens for clearing a deficiency of testosterone with prostate protection agents.

Use of a natural or synthetic androgenic agent in combination with a component selected from the group of the gestagens, for the preparation of a combination formulation intended for the compensation of an absolute or relative testosterone deficiency with simultaneous prophylaxis for the genesis of a benign prostatic hyperplasia (BPH) or prostate carcinoma.